Ado-trastuzumab emtansine Intravenous and Epoetin beta and methoxy polyethylene glycol

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: n.a.
• Other Brand Names: Kadcyla

Ado-trastuzumab emtansine injection is used to treat HER2-positive metastatic breast cancer (cancer that has spread to other parts of the body) in patients who have already received other medicines that did not work well. HER2 protein is produced by some breast tumors. Ado-trastuzumab emtansine interferes with the growth of this protein which also prevents tumor growth. The tumor cells will then be destroyed by the body.

Ado-trastuzumab emtansine is to be given only by or under the immediate supervision of your doctor.

• Generic Name: epoetin beta-methoxy polyethylene glycol
• Dosage Forms: n.a.
• Other Brand Names: Mircera

Epoetin beta and methoxy polyethylene glycol is a combination medicine used to treat anemia (lack of red blood cells) and to reduce the need for blood cell transfusions.

Epoetin beta and methoxy polyethylene glycol is used to treat anemia caused by chronic kidney disease in adults, or in children at least 5 years old who are on hemodialysis.

epoetin beta and methoxy polyethylene glycol is not for treating anemia caused by cancer chemotherapy. Epoetin beta and methoxy polyethylene glycol may increase tumor growth or decrease survival time in people with certain types of cancer.

Epoetin beta and methoxy polyethylene glycol should not be used to take the place of an emergency blood cell transfusion.

Epoetin beta and methoxy polyethylene glycol may also be used for purposes not listed in this medication guide.